Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Symbicort SMART versus fixed-dose Symbicort plus terbutaline in asthma
jRCT2080220715Phase 3
- Sponsor
- AstraZeneca
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (2 arms), sponsored by AstraZeneca.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080220715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220715.